Aurora Cannabis (ACBFF) Stock Price, News & Analysis

Company Overview

Aurora Cannabis Inc. (OTCMKTS:ACBFF) is a licensed producer of medical and recreational cannabis products headquartered in Edmonton, Alberta. The company cultivates, processes and distributes a variety of cannabis-derived products under several proprietary brands. Since its founding in 2013, Aurora has focused on leveraging advanced greenhouse and indoor cultivation technologies to drive consistent supply and quality control across its operations.

Aurora’s product portfolio includes dried-flower cannabis, pre-rolls, vape cartridges, oils, softgel capsules and an expanding line of edibles and beverages. The company also develops extracts and concentrates for both adult-use and medical markets, and offers value-added formulations such as topicals and wellness products. Aurora’s manufacturing facilities are designed to meet rigorous health-care standards, enabling the company to supply pharmacies, hospitals and cannabis retailers with pharmaceutical-grade cannabis under controlled conditions.

With a global footprint spanning Canada, Europe, Latin America and Australia, Aurora has established production and distribution channels in key regulated markets. In Europe, the company holds cultivation and distribution licenses in countries such as Germany, Denmark and Italy. In Latin America, it operates in markets including Chile and Uruguay. Aurora also maintains research partnerships in Australia focused on clinical trials and pharmacological studies, supporting the advancement of cannabis-based therapies.

Originally co-founded by Terry Booth, Steve Dobler and Chris Mayerson, Aurora Cannabis has grown through strategic acquisitions and capital investments in cultivation infrastructure. Under the leadership of Chief Executive Officer Miguel Martin, the company has shifted toward operational efficiencies and strategic brand building. Aurora’s management team brings experience in pharmaceuticals, consumer packaged goods and biotechnology, positioning the company to navigate evolving regulatory landscapes and pursue long-term growth in the global cannabis industry.

Key Stats

• Today's Range: $4.47 to $4.67
• 50-Day Range: $3.92 to $6.09
• 52-Week Range: $2.20 to $12.53
• Volume: 864,357 shs
• Average Volume: 4.22 million shs
• Market Capitalization: $4.31 billion
• P/E Ratio: 37.42
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACBFF Stock Analysis - Frequently Asked Questions

How have ACBFF shares performed this year?

Aurora Cannabis' stock was trading at $4.25 on January 1st, 2025. Since then, ACBFF stock has increased by 5.6% and is now trading at $4.49.

Does Aurora Cannabis have any subsidiaries?

The following companies are subsidiaries of Aurora Cannabis: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and others.

How do I buy shares of Aurora Cannabis?

Shares of ACBFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ACBFF
• CIK: N/A
• Web: auroramj.com
• Phone: 844-928-7672
• Fax: N/A
• Employees: 1,340
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 37.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 960,960,000
• Free Float: N/A
• Market Cap: $4.31 billion
• Optionable: Not Optionable
• Beta: N/A